• info@calysta.eu
Alternative and Strategic Intellectual Property Services
  • Home
  • Services
    • Patents
      • Unitary Patent & UPC
    • Trademarks
    • Designs
    • Due Diligence
    • Landscaping of IP environment
    • Contracting
    • Building smart invention declaration processes
    • Implementation of guidelines for managing IP
    • Trade secrets
    • IP Stategy
    • Ranking / scoring of IP portfolio
    • Valorization through intercompany structuring
    • Valorization of IP
    • Innovation tax deduction 
  • About
    • Vision
    • Mission
  • News & Publications
    • News & Publications
    • German desk
    • Calysta Awards
    • IP VIDEOS
  • Team
  • Contact
  • Login
  • EN
    • NL
    • FR
Calysta
Calysta
  • Home
  • Services
    • Patents
      • Unitary Patent & UPC
    • Trademarks
    • Designs
    • Due Diligence
    • Landscaping of IP environment
    • Contracting
    • Building smart invention declaration processes
    • Implementation of guidelines for managing IP
    • Trade secrets
    • IP Stategy
    • Ranking / scoring of IP portfolio
    • Valorization through intercompany structuring
    • Valorization of IP
    • Innovation tax deduction 
  • About
    • Vision
    • Mission
  • News & Publications
    • News & Publications
    • German desk
    • Calysta Awards
    • IP VIDEOS
  • Team
  • Contact
  • Login
  • EN
    • NL
    • FR
  1. Home /
  2. Articles posted by Caner Yelek
Why deleting all IP laws is a risky proposition for innovation, especially in healthcare

Why deleting all IP laws is a risky proposition for innovation, especially in healthcare

Video Articles  |   26 May 2025  |  Caner Yelek
Why deleting all IP laws is a risky proposition for innovation, especially in healthcare A tweet from Jack Dorsey, co-founder and former CEO of Twitter, recently stirred debate across the
EUIPPatent
Not every invention looks like a breakthrough; Rethinking what counts as an invention

Not every invention looks like a breakthrough; Rethinking what counts as an invention

Video Articles  |   19 May 2025  |  Caner Yelek
What is an invention ? As a scientist stepping into the world of patents, I’ve come to appreciate a fascinating divergence in perspective between scientific research and intellectual property. For
EUIPPatent

Recent news

  • Interview Peter Buckinx Calysta in the USA 24 June 2025
  • Calysta at INTA 2025 24 June 2025
  • New decision of the Enlarged Board of Appeal (EBoA) of the European Patent Office (EPO) 19 June 2025

Category

  • Articles
  • Interview
  • Press
  • Uncategorized

Tags

Annuity BigMac copyright counterfeiting Design Designs Entrepreneurship EU EUIPO EUTM Fashion Food Germandesk German Law Germany Innovation Intellectual Property interview invention IP IP firm IP rights IP STARS ipstars IP Strategy Licenses licensing Litigation McDonalds Octrooien Patent patent box pharma Press article Protection Rankings Software Technology Trademark Trademarks Trade Secret Unitary Patent UPC Valentin WorldIPDay

Calysta - Belgium

VAT: BE0686.655.773

BRUSSELS (Diegem)

c/o Bloomz Offices
Lambroekstraat 5A
1831 Diegem

LIEGE

c/o Val Benoit
Quai Banning 6
4000 Liège

LIEGE (Seraing)

c/o The Labs
Rue Bois Saint Jean 15/1
4102 Seraing

CHARLEROI 

c/o Monkey Bridge
Rue Antoine de St-Exupéry 2
6041 Charleroi

ANTWERP

c/o Cloudhouse
Delacenseriestraat14
2018 Antwerpen

Calysta – Germany

Service address for representation at German Patent and Trademark office

Calysta – Italy

Service address

Calysta – Switzerland

Service address for representation at Swiss Patent and Trademark office

Calysta – Ghent

c/o In The Yard
Landegemstraat 10
9031 Drongen

We are accredited to obtain subsidies from the bodies listed below. Contact us for more information.

© Calysta NV •  General Terms FR - EN - NL  •  Privacy Policy
  • info@calysta.eu